Literature DB >> 15684405

Activation of SOCS-3 by resistin.

Claire M Steppan1, Juan Wang, Eileen L Whiteman, Morris J Birnbaum, Mitchell A Lazar.   

Abstract

Resistin is an adipocyte hormone that modulates glucose homeostasis. Here we show that in 3T3-L1 adipocytes, resistin attenuates multiple effects of insulin, including insulin receptor (IR) phosphorylation, IR substrate 1 (IRS-1) phosphorylation, phosphatidylinositol-3-kinase (PI3K) activation, phosphatidylinositol triphosphate production, and activation of protein kinase B/Akt. Remarkably, resistin treatment markedly induces the gene expression of suppressor of cytokine signaling 3 (SOCS-3), a known inhibitor of insulin signaling. The 50% effective dose for resistin induction of SOCS-3 is approximately 20 ng/ml, close to levels of resistin in serum. Association of SOCS-3 protein with the IR is also increased by resistin. Inhibition of SOCS function prevented resistin from antagonizing insulin action in adipocytes. SOCS-3 induction is the first cellular effect of resistin that is independent of insulin and is a likely mediator of resistin's inhibitory effect on insulin signaling in adipocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684405      PMCID: PMC548000          DOI: 10.1128/MCB.25.4.1569-1575.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.

Authors:  Michael W Rajala; Silvana Obici; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  A new role for SOCS in insulin action. Suppressor of cytokine signaling.

Authors:  Danielle L Krebs; Douglas J Hilton
Journal:  Sci STKE       Date:  2003-02-11

3.  Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation.

Authors:  Byoung Moon; Jamie Jun-Mae Kwan; Noreen Duddy; Gary Sweeney; Najma Begum
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-03-04       Impact factor: 4.310

4.  Serum resistin level in essential hypertension patients with different glucose tolerance.

Authors:  J-L Zhang; Y-W Qin; X Zheng; J-L Qiu; D-J Zou
Journal:  Diabet Med       Date:  2003-10       Impact factor: 4.359

5.  Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes.

Authors:  Philippe Gual; Teresa Gonzalez; Thierry Grémeaux; Romain Barres; Yannick Le Marchand-Brustel; Jean-François Tanti
Journal:  J Biol Chem       Date:  2003-05-01       Impact factor: 5.157

6.  Correlation between serum resistin level and adiposity in obese individuals.

Authors:  Koichiro Azuma; Fuminori Katsukawa; Shuji Oguchi; Mitsuru Murata; Hajime Yamazaki; Akira Shimada; Takao Saruta
Journal:  Obes Res       Date:  2003-08

7.  Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates.

Authors:  Eileen L Whiteman; Janine J Chen; Morris J Birnbaum
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

8.  Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus.

Authors:  Byung-Soo Youn; Kang-Yeol Yu; Hong Je Park; Nam Seok Lee; Sung Shik Min; Moon Yeon Youn; Young Min Cho; Young Joo Park; Seong Yeon Kim; Hong Kyu Lee; Kyong Soo Park
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

9.  Serum resistin (FIZZ3) protein is increased in obese humans.

Authors:  Mikako Degawa-Yamauchi; Jason E Bovenkerk; Beth Elisa Juliar; William Watson; Kimberly Kerr; RoseMarie Jones; Qihong Zhu; Robert V Considine
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

Review 10.  Modulators of insulin action and their role in insulin resistance.

Authors:  L Pirola; A M Johnston; E Van Obberghen
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12
View more
  63 in total

1.  Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor.

Authors:  Beatriz Sánchez-Solana; Jorge Laborda; Victoriano Baladrón
Journal:  Mol Endocrinol       Date:  2011-11-10

Review 2.  Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy.

Authors:  Meera G Nair; Katherine J Guild; David Artis
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 3.  New weapons in the war on worms: identification of putative mechanisms of immune-mediated expulsion of gastrointestinal nematodes.

Authors:  David Artis
Journal:  Int J Parasitol       Date:  2006-03-13       Impact factor: 3.981

Review 4.  Human resistin: found in translation from mouse to man.

Authors:  Daniel R Schwartz; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

5.  Hypothalamic resistin induces hepatic insulin resistance.

Authors:  Evan D Muse; Tony K T Lam; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

6.  Resistin-like molecule alpha reduces gallbladder optimal tension.

Authors:  Hayder H Al-Azzawi; Abhishek Mathur; Debao Lu; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

Review 7.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

Review 8.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

9.  Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells.

Authors:  Zhaofan Luo; Ying Zhang; Fangping Li; Juan He; Helin Ding; Li Yan; Hua Cheng
Journal:  Endocrine       Date:  2009-05-08       Impact factor: 3.633

10.  Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.

Authors:  Mohammed Qatanani; Nava R Szwergold; David R Greaves; Rexford S Ahima; Mitchell A Lazar
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.